ArticleTherapeutic innovation & regulatory science2020

Quality Decision-Making Practices in Pharmaceutical Companies and Regulatory Authorities: Current and Proposed Approaches to Its Documentation.

Magdalena Bujar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.